Exploratory analysis of the proteomic profile in plasma in adults with Down syndrome in the context of Alzheimer's disease
Authors:
Open Access
- 20 March 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (3) , e70040
Abstract
INTRODUCTION: Adults with Down syndrome (DS) show increased risk for Alzheimer's disease (AD) due to the triplication of chromosome 21 encoding the amyloid precursor protein gene. Further, this triplication possibly contributes to dysregulation of the immune system, furthering AD pathophysiology.METHODS: Using Olink Explore 3072, we measured ∼3000 proteins in plasma from 73 adults with DS and 15 euploid, healthy controls (HC). Analyses for differentially expressed proteins (DEP) were carried out, and pathway and protein network enrichment using Gene Ontology, Kyoto Encyclopedia of Genes and Genomes (KEGG), and STRING database was investigated. Within DS, the LASSO (least absolute shrinkage and selection operator) feature selection was applied.RESULTS: We identified 253 DEP between DS and HC and 142 DEP between symptomatic and asymptomatic DS. Several pathways regarding inflammatory and neurodevelopmental processes were dysregulated in both analyses. LASSO feature selection within DS returned 15 proteins as potential blood markers.DISCUSSION: This exploratory proteomic analysis found potential new blood biomarkers for diagnosing DS‐AD in need of further investigation.Highlights: Inflammatory pathways are dysregulated in symptomatic versus asymptomatic DS. NFL and GFAP are confirmed as powerful biomarkers in DS with clinical and/or cognitive decline. Further circulating proteins were identified as potential blood biomarkers for symptomatic DS.Keywords
Funding Information
- Alzheimer Forschung Initiative (#22049)
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung (2020_EKEA.09)
- National Institutes of Health (R01 AG056850, R21 AG056974, R01 AG061566, R01 AG081394, R61AG066543)
- Fundación Tatiana Pérez de Guzmán el Bueno (IIBSP‐DOW‐2020‐151)
This publication has 78 references indexed in Scilit:
- Diagnosing Alzheimer's dementia in Down syndrome: Problems and possible solutionsResearch in Developmental Disabilities, 2009
- Down syndrome--recent progress and future prospectsHuman Molecular Genetics, 2009
- RESEARCH ARTICLE: Neurogenesis Impairment and Increased Cell Death Reduce Total Neuron Number in the Hippocampal Region of Fetuses with Down SyndromeBrain Pathology, 2008
- Symptoms of dementia among adults with Down's syndrome: a qualitative studyJournal of Intellectual Disability Research, 2007
- Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down SyndromeArchives of Neurology, 2007
- Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn miceHippocampus, 2007
- Binding of F-spondin to amyloid-β precursor protein: A candidate amyloid-β precursor protein ligand that modulates amyloid-β precursor protein cleavageProceedings of the National Academy of Sciences, 2004
- The Gene Ontology (GO) database and informatics resourceNucleic Acids Research, 2004
- Septin 3 Gene Polymorphism in Alzheimer’s DiseaseGene Expression, 2003
- Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.2001